Opus Genetics, Inc. - IRD
About Gravity Analytica
Recent News
- 02.13.2026 - Opus Genetics Announces $25 Million Private Placement
- 02.02.2026 - Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
- 01.27.2026 - Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
- 01.08.2026 - Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts
Recent Filings
- 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.26.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.22.2026 - S-8 Securities to be offered to employees in employee benefit plans
- 01.21.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.13.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.12.2026 - 8-K Current report